Gaudium IVF Women Health IPO : Expanding India’s Assisted Reproductive Technology Network

The Gaudium IVF Women Health IPO is set to open in February 2026, marking a significant milestone in India’s evolving fertility and reproductive healthcare space. The Gaudium IVF IPO brings focus to the fast-growing IVF and women health segment under the formal regulatory framework of the ART Act 2021.

Gaudium IVF and Women Health Limited is a Delhi NCR-based fertility chain offering advanced assisted reproductive technology, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction.

With a strong hub-and-spoke model, growing financial performance, and expansion into underserved regions, the IVF women health IPO is attracting attention from retail investors and healthcare-focused investors alike.

Gaudium IVF Women Health IPO – IPO Details

The Gaudium IVF IPO opens during the subscription period from February 20 to February 24, 2026.

Registrar: Bigshare Services

Lead Manager: Sarthi Capital Advisors

Retail investors must review the company website and offer documents carefully.

IPO Timetable (Subscription Period & Key Dates)

The tentative listing date for the health IPO is February 27, 2026.

Gaudium IVF and Women – Company Overview

Gaudium IVF and Women Health Limited provides reproductive healthcare services across India. The company specializes in:

• IVF treatments

• Intracytoplasmic sperm injection

• Intrauterine insemination

• Ovulation induction

• Advanced sperm retrieval techniques

• High risk pregnancy management

The company operates over thirty locations including:

• Seven hubs (central hubs)

• Twenty-eight spokes

Major hubs are located in:

• New Delhi (Kailash Colony, Janak Puri)

• Khar West (Mumbai)

• Other multiple states across India

The hub-and-spoke model allows advanced procedures like ICSI and vitro fertilisation to be conducted at central hubs, while spoke centres manage consultations and follow-ups.

Gaudium IVF serves patients from various countries including:

• United States

• United Kingdom

• Canada

• Kenya

• South Africa

• Oman

This gives the company growing international exposure in the IVF market.

IVF and Women Health – Business Model

The business model of Gaudium IVF women health revolves around a structured hub-and-spoke system:

• Central hubs perform advanced procedures.

• Spokes handle patient screening, consultations, and follow-up.

• Standardized operating procedures reduce practitioner dependency.

The company operates in the rapidly expanding IVF market in India. Rising infertility awareness, delayed parenthood, and improved access to reproductive healthcare services are driving demand.

Expansion Strategy:

• Establish 19 new IVF centers across India.

• Target underserved regions.

• Improve accessibility to high-quality IVF treatments.

• Expand pan India presence.

Additionally, the company plans to enter the FMCG space through EKK Global, launching mother-and-child wellness products.

Gaudium IVF IPO Opens – Objectives of the Issue

The fresh issue proceeds from the Gaudium IVF Women Health IPO will be used for:

• ₹20 crore for repayment or pre-payment of certain outstanding loans.

• Capital expenditure for new IVF centers.

• Purchase of advanced medical equipment.

• General corporate purposes.

The IPO strengthens the company’s financial position and supports expansion across multiple states in India.

Gaudium IVF Women – Financial Performance

Financial Performance (₹ Crore)

Key Highlights:

• Revenue increased from ₹44.24 crore (FY23) to ₹70.72 crore (FY25).

• PAT increased 85.39% YoY in FY25.

• 3,476 IVF treatment cycles performed in FY25.

• Strong growth in patient engagement during H1FY26.

The company operates with improving profitability and steady financial performance in the women health sector.

Allotment & Listing – Health IPO

The Gaudium IVF IPO date runs from February 20 to February 24, 2026.

• Allotment Date: February 25, 2026

• Listing Date: February 27, 2026

• Upper Price Band: ₹79

• Issue Price within ₹75–₹79 range

Shares will be credited to the investor’s demat account before listing.

How to Apply – Demat Account Process

To apply for the Gaudium IVF Women Health IPO:

• Ensure active Tradejini demat account

• Link bank account for UPI authorization.

• Apply via CubePlus platform when IPO opens.

• Select cut-off or bid price within price band.

• Authorize payment

Business Expansion & Future Outlook

Gaudium IVF Women Health aims to:

• Expand new IVF centers.

• Increase pan India presence.

• Strengthen reproductive health services.

• Formalize fertility treatment under ART Act compliance.

• Improve accessibility in underserved regions.

The structured hub-and-spoke model enables operational scalability while maintaining standardized medical quality.

Conclusion – Should Investors Consider This Health IPO?

The Gaudium IVF Women Health IPO offers exposure to India’s expanding fertility and assisted reproductive technology market.

Strengths:

• Strong revenue growth

• Improving profitability

• Structured hub-and-spoke model

• Expansion into 19 new IVF centers

• Rising IVF market demand

Risks:

• Healthcare regulation

• Competitive IVF market

• Dependence on medical specialists

• Outstanding loans

For investors seeking healthcare and women health exposure, this IVF IPO presents a growing niche opportunity.